{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/corticosteroids-inhaled/background-information/types-of-inhaled-corticosteroids/","result":{"pageContext":{"chapter":{"id":"64e8ade1-73c2-542d-b449-ad660d98768b","slug":"types-of-inhaled-corticosteroids","fullItemName":"Types of inhaled corticosteroids","depth":2,"htmlHeader":"<!-- begin field c3068dd9-15f5-4282-be88-e8f43b91e1fa --><h2>Which inhaled corticosteroids are available in the UK?</h2><!-- end field c3068dd9-15f5-4282-be88-e8f43b91e1fa -->","summary":"","htmlStringContent":"<!-- begin item 93023228-d829-485e-b44f-c465237311b3 --><!-- begin field d63111ff-36fe-47e5-ac18-2eb6695bf9fa --><ul><li>Inhaled corticosteroids are available in a wide range of <a class=\"topic-reference internal-reference\" href=\"/topics/corticosteroids-inhaled/management/corticosteroids-inhaled/#available-delivery-systems\">delivery systems</a> that administer the drug directly to the lungs. These include pressurized metered-dose inhalers (pMDIs), breath-actuated inhalers (BA-MDIs), and dry powder inhalers (DPIs).</li><li>Inhaled corticosteroids available in the UK include:<br><ul><li>Beclometasone dipropionate (pMDI and DPI).</li><li>Budesonide (DPI and single-dose units for nebulization).</li><li>Ciclesonide (pMDI).</li><li>Fluticasone propionate (DPI, pMDI, and single-dose units for nebulization).</li><li>Mometasone furoate (DPI).</li></ul></li><li>See Table 1 for details of available corticosteroid inhalers.</li></ul><p><strong>Table 1.</strong> Corticosteroid inhalers</p><table data-table-id=\"d4f1c8b4-6781-4e46-b7cc-acce014ef9c2\"><thead><tr><th scope=\"col\"><strong>Corticosteroid</strong></th><th scope=\"col\"><strong>Available products</strong></th></tr></thead><tbody><tr><td>Beclometasone dipropionate</td><td><p>Clenil Modulite MDI</p><p>Easyhaler beclometasone</p><p>Kelhale MDI</p><p>QVAR MDI</p><p>QVAR Autohaler</p><p>QVAR Easi-Breathe</p><p>Soprobec MDI</p></td></tr><tr><td>Budesonide</td><td><p>Budelin Novolizer</p><p>Easyhaler Budesonide</p><p>Pulmicort Turbohaler</p></td></tr><tr><td>Ciclesonide</td><td>Alvesco MDI</td></tr><tr><td>Fluticasone propionate</td><td><p>Flixotide Evohaler MDI</p><p>Flixotide Accuhaler</p></td></tr><tr><td>Mometasone furoate</td><td>Asmanex Twisthaler</td></tr><tr><td colspan=\"2\">Data from [<a class=\"bibliography-reference internal-reference\" href=\"/topics/corticosteroids-inhaled/references/\">BTS/SIGN, 2019</a>]</td></tr></tbody></table><ul><li>Inhaled corticosteroids are also available as compound preparations containing long-acting beta-2 agonists. <ul><li>Beclometasone and formoterol pMDI.</li><li>Budesonide and formoterol DPI.</li><li>Fluticasone propionate and formoterol.</li><li>Fluticasone propionate and salmeterol pMDI and DPI.</li><li>Fluticasone furoate and vilanterol DPI.</li></ul></li><li>See Table 2 for details of available products.</li></ul><p><strong>Table 2.</strong> Combined corticosteroid inhalers  </p><table data-table-id=\"ff88161f-22a7-45af-a116-acce014ef9c2\"><thead><tr><th scope=\"col\"><strong>Corticosteroid</strong></th><th scope=\"col\"><strong>Beta-2 agonist</strong></th><th scope=\"col\"><strong>Available products</strong></th></tr></thead><tbody><tr><td>Beclometasone dipropionate</td><td>Formoterol</td><td><p>Fostair pMDI</p><p>Fostair NEXThaler</p></td></tr><tr><td>Budesonide</td><td>Formoterol</td><td><p>DuoResp Spiromax</p><p>Symbicort Turbohaler</p><p>Fobumix Easyhaler </p></td></tr><tr><td>Fluticasone propionate</td><td>Formoterol</td><td><p>Flutiform MDI</p><p>Flutiform K-haler </p></td></tr><tr><td>Fluticasone propionate</td><td>Salmeterol</td><td><p>AirFluSal Forspiro </p><p>AirFluSal pMDI </p><p>Aloflute pMDI </p><p>Combisal pMDI </p><p>Fusacomb Easyhaler </p><p>Sereflo pMDI </p><p>Seretide Accuhaler</p><p>Seretide Evohaler</p><p>Sirdupla pMDI</p><p>Stalpex </p></td></tr><tr><td>Fluticasone furoate</td><td>Vilanterol</td><td>Relvar Ellipta</td></tr><tr><td colspan=\"3\">Data from [<a class=\"bibliography-reference internal-reference\" href=\"/topics/corticosteroids-inhaled/references/\">BTS/SIGN, 2019</a>]</td></tr></tbody></table><!-- end field d63111ff-36fe-47e5-ac18-2eb6695bf9fa --><!-- end item 93023228-d829-485e-b44f-c465237311b3 -->","topic":{"id":"754932e3-62ea-5d15-b61d-d5a5d6f4fe71","topicId":"702fbe32-706c-43c3-bc60-c5cc8f25f0a7","topicName":"Corticosteroids - inhaled","slug":"corticosteroids-inhaled","lastRevised":"Last revised in May 2020","chapters":[{"id":"e16eda3c-cfc9-5314-bbcf-81f1103a5e06","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"efb2ce33-0722-5c31-9322-cba88887d787","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"39f35fad-0659-5902-87b2-552b35242d2d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2f4cdb72-e152-55d0-ae30-3f5af0898296","slug":"changes","fullItemName":"Changes"},{"id":"efff15e7-d3fb-5f90-b3f8-6e71440ba7a9","slug":"update","fullItemName":"Update"}]},{"id":"1cb3cdc7-d58b-55c4-a4dc-45e54579d133","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"416f2419-bb3a-58d9-aea2-5f7507d47ae6","slug":"goals","fullItemName":"Goals"},{"id":"f0acbcc7-6859-5e5a-97f1-55768a7a7112","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e5608261-290b-5500-aec0-ba1898b40aa8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"627a8419-15f6-51a5-bd61-09cd8079faaa","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8650965c-ede6-5616-a913-25e614b34788","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a1969d6e-782d-5f6b-aa7a-865b57819d63","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d64ef1a8-021d-5652-a94f-b6a774c0859a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"09abff45-ce37-5d8b-aa7a-22ccb00d395b","slug":"definition","fullItemName":"Definition"},{"id":"05a81ed7-5f38-5cdb-9632-25d4c2e2bdcc","slug":"action-of-inhaled-corticosteroids","fullItemName":"Action of inhaled corticosteroids"},{"id":"64e8ade1-73c2-542d-b449-ad660d98768b","slug":"types-of-inhaled-corticosteroids","fullItemName":"Types of inhaled corticosteroids"}]},{"id":"91b69720-7ebf-581e-982f-dbdd23431ed6","fullItemName":"Management","slug":"management","subChapters":[{"id":"a547f7e2-e032-5c44-8261-cea196fc4d68","slug":"corticosteroids-inhaled","fullItemName":"Scenario: Corticosteroids - inhaled"}]},{"id":"bd9a7839-1db9-5989-b6e2-1dca5e05011d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"911e76ba-1f8e-5933-9443-46079dc58b6e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c1740827-55f4-59ff-be70-58d37950d253","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"89f98a44-5528-5143-a4a4-7191fb4e63a5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d1f364ad-9716-533d-be8e-e76d8756114d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f271d3a7-f87a-5588-ba5e-8a5f5a6f9cb4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ac4dbca5-4c83-52b2-b0ac-a8b7bd478cf0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ccd99bc8-bb83-57ec-be29-e083eabb4915","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d64ef1a8-021d-5652-a94f-b6a774c0859a","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}